Latest Breaking News On - Renal autologous cell therapy - Page 7 : comparemela.com

ProKidney Corp (NASDAQ:PROK) Q3 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the ProKidney Corporate Update Conference Call. At this time, all lines are in a listen-only mode.

United statesPablo legorretaDarin weberGlenn schulmanBruce culletonYigal nochomovitzAlan lotvinTim bertramBrian pereiraJames coulstonProkidney corpUniversity of calgaryNational kidney foundationProkidney coCall transcript novemberProkidney corporate update conference

ProKidney Corp (NASDAQ:PROK) Major Shareholder Sells $138,299 00 in Stock

ProKidney Corp (NASDAQ:PROK) Major Shareholder Sells $138,299 00 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesChamath palihapitiyaTower research capitalLazard asset managementSalem investment counselors incSecurities exchange commissionProkidney corpGet free reportExchange commissionWisconsin investment boardResearch capitalInvestment counselorsKidney corpRenal autologous cell therapyCongenital anomaliesUrinary tract

ProKidney (NASDAQ:PROK) Releases Quarterly Earnings Results

ProKidney (NASDAQ:PROK) Releases Quarterly Earnings Results
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United statesChamath palihapitiyaProkidney corpLazard asset managementProkidney company profileTower research capitalGet free reportMarketwatch earningsWisconsin investment boardResearch capitalAsset managementKidney corpRenal autologous cell therapyCongenital anomaliesUrinary tractProkidney daily

ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates

ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Glenn schulmanTim bertramBruce culletonPablo legorretaProkidney corpMaster degree in business administrationKellogg school of managementRoyal college of physiciansExchange commissionNorthwestern universityClinical developmentCompany classBoston universityMemorial university of newfoundlandQualified person auditExecutive vice president

ProKidney sets CEO shift, discloses manufacturing pause

ProKidney sets CEO shift, discloses manufacturing pause
journalnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from journalnow.com Daily Mail and Mail on Sunday newspapers.

Bruce culletonPablo legorretaTim bertramDrug administrationProkidney corpClinical developmentEuropean unionBusiness centerRenal autologous cell therapyGreenbourne drive